share_log

华大基因:控股股东计划减持公司股份不超过2%

bgi genomics: The controlling shareholder plans to reduce its shareholding in the company by no more than 2%.

Breakings ·  Nov 25 20:42

bgi genomics announced that the controlling shareholder, bgi holding, plans to reduce its shareholding in the company through block trades by no more than 8,316,432 shares, which is no more than 2% of the company's total share capital.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment